Bill Pappas - Feb 27, 2024 Form 4 Insider Report for METLIFE INC (MET)

Role
EVP, Global Tech. & Ops.
Signature
/s/ Anna Nazarenko, Authorized Signer
Stock symbol
MET
Transactions as of
Feb 27, 2024
Transactions value $
-$2,071,964
Form type
4
Date filed
2/29/2024, 04:20 PM
Previous filing
Sep 5, 2023
Next filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award +9.33K +19.88% 56.2K Feb 27, 2024 Direct F1, F2
transaction MET Common Stock Award +62.9K +111.89% 119K Feb 27, 2024 Direct F3
transaction MET Common Stock Tax liability -$2.07M -30K -25.14% $69.16 89.2K Feb 27, 2024 Direct F4
holding MET Common Stock 7.9K Feb 27, 2024 By 2022 GRAT F2
holding MET Common Stock 17.3K Feb 27, 2024 By 2023 GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MET Employee Stock Options (right to buy) Award $0 +28K $0.00 28K Feb 27, 2024 Common Stock 28K $69.16 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
F2 On November 15, 2023, 7,400 shares were distributed to the reporting person in accordance with the terms of the 2022 GRAT, and are now reported as directly owned.
F3 Shares acquired from the determination of the performance factor for and payout of 2021-2023 performance shares under the MetLife, Inc. 2015 Stock and Incentive Compensation.
F4 Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout.
F5 The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.